Combined TRPC3 and TRPC6 blockade by selective small-molecule or genetic deletion inhibits pathological cardiac hypertrophy (Proceedings of the National Academy of Sciences of the United States of America (2014) 111, 4, (1551-1556) doi: 10.1073/pnas.1308963111)